Scarica l'app Stockscreener
7.63
2.55%
-0.20
Dopo l'orario di chiusura:
7.55
-0.08
-1.05%
Precedente Chiudi:
$7.83
Aprire:
$7.87
Volume 24 ore:
835.91K
Relative Volume:
0.67
Capitalizzazione di mercato:
$407.07M
Reddito:
$1.02B
Utile/perdita netta:
$-757.20M
Rapporto P/E:
-0.5169
EPS:
-14.76
Flusso di cassa netto:
$-257.90M
1 W Prestazione:
-9.06%
1M Prestazione:
+28.24%
6M Prestazione:
+19.41%
1 anno Prestazione:
+3.25%
Intervallo 1D:
$7.53
$7.87
Intervallo di 1 settimana:
$7.53
$8.62
Portata 52W:
$4.02
$12.73
Emergent Biosolutions Inc Stock (EBS) Company Profile
Nome
Emergent Biosolutions Inc
Settore
Telefono
240-631-3200
Indirizzo
300 PROFESSIONAL DR, GAITHERSBURG, MD
Confronta EBS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EBS
Emergent Biosolutions Inc
|
7.63 | 438.01M | 1.02B | -757.20M | -257.90M | -14.76 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-30 | Iniziato | H.C. Wainwright | Buy |
| 2024-08-22 | Iniziato | Rodman & Renshaw | Buy |
| 2024-03-07 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2023-11-20 | Ripresa | JP Morgan | Underweight |
| 2023-08-29 | Downgrade | The Benchmark Company | Buy → Hold |
| 2023-04-10 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2023-03-17 | Downgrade | JP Morgan | Neutral → Underweight |
| 2022-11-10 | Downgrade | The Benchmark Company | Buy → Hold |
| 2022-04-29 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2022-01-20 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2021-11-08 | Downgrade | The Benchmark Company | Buy → Hold |
| 2021-05-05 | Downgrade | Argus | Buy → Hold |
| 2021-04-07 | Iniziato | The Benchmark Company | Buy |
| 2021-02-24 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2021-02-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2021-01-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-09-14 | Ripresa | JP Morgan | Neutral |
| 2020-07-31 | Reiterato | Chardan Capital Markets | Buy |
| 2019-09-12 | Iniziato | Guggenheim | Buy |
| 2019-09-04 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2018-11-02 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-08-03 | Reiterato | Chardan Capital Markets | Buy |
| 2018-06-13 | Iniziato | Argus | Buy |
| 2018-04-25 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2018-01-24 | Iniziato | Goldman | Neutral |
| 2018-01-16 | Reiterato | Chardan Capital Markets | Buy |
| 2016-06-28 | Reiterato | Singular Research | Buy |
| 2016-04-15 | Iniziato | Chardan Capital Markets | Buy |
| 2016-03-28 | Iniziato | Singular Research | Buy |
| 2016-02-19 | Iniziato | Wells Fargo | Outperform |
| 2014-05-15 | Iniziato | Summer Street Research | Buy |
| 2011-05-31 | Reiterato | WBB Securities | Strong Buy |
| 2011-01-10 | Reiterato | Wedbush | Outperform |
| 2010-11-05 | Reiterato | Wedbush | Outperform |
| 2010-08-18 | Aggiornamento | WBB Securities | Buy → Strong Buy |
| 2010-08-06 | Reiterato | Caris & Company | Buy |
Mostra tutto
Emergent Biosolutions Inc Borsa (EBS) Ultime notizie
Mineralys’ strategic stock sale; Gilead, Shoreline partnership ends - Endpoints News
What high frequency data says about Emergent BioSolutions Inc.July 2025 Short Interest & Weekly Chart Analysis and Guides - Newser
Smart tools for monitoring Emergent BioSolutions Inc.’s price actionJuly 2025 Snapshot & Entry and Exit Point Strategies - Newser
How to build a custom watchlist for Emergent BioSolutions Inc.2025 Trading Volume Trends & AI Driven Stock Reports - Newser
Can Emergent BioSolutions Inc. hit a new high this monthBear Alert & Expert Curated Trade Setups - Newser
Building trade automation scripts for Emergent BioSolutions Inc.2025 Earnings Impact & Technical Pattern Recognition Alerts - Newser
Ranking Emergent BioSolutions Inc. among high performing stocks via tools2025 Price Action Summary & Momentum Based Trading Ideas - Newser
Tools to assess Emergent BioSolutions Inc.’s risk profile2025 Price Action Summary & Free Real-Time Volume Trigger Notifications - Newser
Emergent: HC Wainwright & Co. reiterates the 'Buy' Rating, The Target Price is $15 - AInvest
Risk vs reward if holding onto Emergent BioSolutions Inc.July 2025 Reactions & Consistent Profit Trade Alerts - Newser
Emergent BioSolutions’ AIGIV Study: A Potential Game-Changer for Anthrax Treatment - MSN
Sector ETF performance correlation with Emergent BioSolutions Inc.July 2025 Intraday Action & Precise Entry and Exit Recommendations - Newser
Is Emergent BioSolutions Inc. forming a bottoming baseWeekly Trend Summary & Long-Term Capital Growth Ideas - Newser
Is Emergent BioSolutions Inc. meeting your algorithmic filter criteriaJuly 2025 Trade Ideas & Long-Term Growth Portfolio Plans - Newser
Applying sector rotation models to Emergent BioSolutions Inc.Global Markets & Daily Technical Forecast Reports - Newser
Real time breakdown of Emergent BioSolutions Inc. stock performanceGold Moves & Precise Entry and Exit Recommendations - Newser
Can a trend reversal in Emergent BioSolutions Inc. lead to recoveryBear Alert & Momentum Based Trading Ideas - Newser
Can trapped investors hope for a rebound in Emergent BioSolutions Inc.2025 Valuation Update & Long-Term Growth Stock Strategies - Newser
Custom watchlist performance reports with Emergent BioSolutions Inc.July 2025 Pullbacks & Safe Capital Growth Stock Tips - Newser
Will Emergent BioSolutions Inc. benefit from green energy policies2025 Price Targets & Community Consensus Trade Alerts - khodrobank.com
Will earnings trigger a reversal in Emergent BioSolutions Inc.July 2025 Selloffs & Low Drawdown Investment Strategies - Newser
Will Emergent BioSolutions Inc. outperform the marketQuarterly Trade Report & Step-by-Step Swing Trade Plans - Newser
Is now a turning point for Emergent BioSolutions Inc.Weekly Market Report & Safe Capital Growth Tips - Newser
Using data models to predict Emergent BioSolutions Inc. stock movementMarket Activity Recap & Real-Time Market Trend Scan - Newser
Is Emergent BioSolutions Inc. trending in predictive chart models2025 Historical Comparison & AI Driven Stock Movement Reports - Newser
Emergent BioSolutions Wins $30 Mln Contract Modicfication To Supply CYFENDUS - Nasdaq
Emergent BioSolutions Inc. Secures $30 Million Contract Modification from BARDA for CYFENDUS® Anthrax Vaccine Supply - Quiver Quantitative
Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use - The Manila Times
$30M Government Contract: Emergent BioSolutions to Supply Critical Two-Dose Anthrax Defense Vaccine - Stock Titan
Published on: 2025-09-02 06:35:51 - Newser
Order flow analysis tools used on Emergent BioSolutions Inc.2025 Risk Factors & AI Based Buy and Sell Signals - Newser
Statistical indicators supporting Emergent BioSolutions Inc.’s strengthPortfolio Performance Summary & Short-Term Swing Trade Alerts - Newser
What’s next for Emergent BioSolutions Inc. stock price2025 Stock Rankings & Daily Entry Point Trade Alerts - Newser
Does Emergent BioSolutions Inc. stock benefit from AI growth2025 Momentum Check & Fast Gaining Stock Reports - khodrobank.com
Heatmap analysis for Emergent BioSolutions Inc. and competitorsJuly 2025 Action & Weekly Return Optimization Alerts - Newser
How to use Fibonacci retracement on Emergent BioSolutions Inc.Market Risk Summary & Community Consensus Picks - Newser
Should you wait for a breakout in Emergent BioSolutions Inc.July 2025 Decliners & Smart Investment Allocation Insights - Newser
Emergent BioSolutions Inc. stock trend outlook and recovery pathMarket Volume Summary & Free Verified High Yield Trade Plans - Newser
Is Emergent BioSolutions Inc. stock a smart retirement pick2025 Big Picture & Fast Moving Trade Plans - خودرو بانک
Can swing trading help recover from Emergent BioSolutions Inc. losses2025 Performance Recap & AI Forecast Swing Trade Picks - Newser
Real time scanner hits for Emergent BioSolutions Inc. explainedQuarterly Trade Report & Community Consensus Trade Alerts - Newser
How moving averages guide Emergent BioSolutions Inc. tradingMarket Growth Report & Community Trade Idea Sharing - Newser
What is the long term forecast for Emergent BioSolutions Inc. stockJuly 2025 Snapshot & Real-Time Chart Breakout Alerts - khodrobank.com
Detecting price anomalies in Emergent BioSolutions Inc. with AI2025 Institutional Moves & Real-Time Stock Movement Alerts - Newser
Emergent Biosolutions Inc Azioni (EBS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.60%
0.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):